The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Alloxan-induced diabetes, a common model for evaluating the glycemic-control potential of therapeutic compounds and plants extracts in experimental studies
Open accessAbstract
Glycemic homeostasis refers to glucose balance or control within circulation in living organisms. It is normally and largely compromised in diabetes. The compromise when exacerbated, leads to several complications including retinopathy, nephropathy and neuropathy which are collectively known as diabetic complications and are the principal actors in co-morbidity and eventual mortality often associated with diabetes. The ability of therapeutic compounds including medicinal plants to restore glycemic balance or homeostasis in hyperglycemic condition is an index of their antidiabetic function and relevance. Alloxan and streptozotocin are the most popular diabetogenic agents used for assessing the antidiabetic or hypoglycemic capacity of test compounds. Notably, alloxan is far less expensive and more readily available than streptozotocin. On this ground, one will logically expect a preference for use of alloxan in experimental diabetes studies. Surprisingly, a sub meta-analysis of randomly selected studies conducted within the last one and half decade revealed otherwise. This observation necessitated the review of alloxan as a diabetogenic agent in animal studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas
Szkudelski, T. (2001) · Physiological Research · doi:10.33549/physiolres.930111 · Cited by 2,876
The mechanisms of alloxan- and streptozotocin-induced diabetes
Lenzen, S. (2008) · Diabetologia · doi:10.1007/s00125-007-0886-7 · Cited by 2,290
DRUGS PRODUCING DIABETES THROUGH DAMAGE OF THE INSULIN SECRETING CELLS
RERUP, C. C. (1970) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06885-1 · Cited by 728
Yadav, H., Jain, S., & Sinha, P. R. (2007) · Nutrition · doi:10.1016/j.nut.2006.09.002 · Cited by 587
Antidiabetic effect of garlic (Allium sativum L.) in normal and streptozotocin-induced diabetic rats
Eidi, A., Eidi, M., & Esmaeili, E. (2006) · Phytomedicine · doi:10.1016/j.phymed.2005.09.010 · Cited by 514
GARLAND, P. B., RANDLE, P. J., & NEWSHOLME, E. A. (1963) · Nature · doi:10.1038/200169a0 · Cited by 425
Jemai, H., El Feki, A., & Sayadi, S. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf901280r · Cited by 379
Maiti, R., Jana, D., Das, U. K., & Ghosh, D. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.02.002 · Cited by 340
Oxidative stress in streptozotocin-induced diabetic rats: effects of garlic oil and melatonin
Anwar, M. M., & Meki, A.-R. M. A. (2003) · Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology · doi:10.1016/s1095-6433(03)00114-4 · Cited by 312
Cited by
Animal models for induction of diabetes and its complications
Qamar, F., Sultana, S., & Sharma, M. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01277-3 · Cited by 24
Metadata
- Authors
- Ighodaro, O. M., Adeosun, A. M., & Akinloye, O. A.
- Venue
- Medicina
- Publisher
- MDPI AG
- Published
- 2017
- Volume
- 53
- Issue
- 6
- Pages
- 365-374
- ISSN
- 1010-660X (ISSN-L)
- OpenAlex
- W2790717534
- Cited by
- 385
- References
- 75
- FWCI
- 10.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alloxan-induced diabetes, a common model for evaluating the glycemic-control potential of therapeutic compounds and plants extracts in experimental studies. https://app.cochat.ai/papers/10.1016/j.medici.2018.02.001
- The paper
- Ighodaro, O. M., Adeosun, A. M., & Akinloye, O. A. (2017). Alloxan-induced diabetes, a common model for evaluating the glycemic-control potential of therapeutic compounds and plants extracts in experimental studies. Medicina. https://doi.org/10.1016/j.medici.2018.02.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.